1. Home
  2. INFU vs STXS Comparison

INFU vs STXS Comparison

Compare INFU & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INFU
  • STXS
  • Stock Information
  • Founded
  • INFU 2005
  • STXS 1990
  • Country
  • INFU United States
  • STXS United States
  • Employees
  • INFU N/A
  • STXS N/A
  • Industry
  • INFU Medical/Dental Instruments
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • INFU Health Care
  • STXS Health Care
  • Exchange
  • INFU Nasdaq
  • STXS Nasdaq
  • Market Cap
  • INFU 104.4M
  • STXS 151.3M
  • IPO Year
  • INFU N/A
  • STXS 2004
  • Fundamental
  • Price
  • INFU $6.16
  • STXS $2.20
  • Analyst Decision
  • INFU
  • STXS
  • Analyst Count
  • INFU 0
  • STXS 0
  • Target Price
  • INFU N/A
  • STXS N/A
  • AVG Volume (30 Days)
  • INFU 286.1K
  • STXS 288.7K
  • Earning Date
  • INFU 08-07-2025
  • STXS 08-11-2025
  • Dividend Yield
  • INFU N/A
  • STXS N/A
  • EPS Growth
  • INFU 3654.89
  • STXS N/A
  • EPS
  • INFU 0.15
  • STXS N/A
  • Revenue
  • INFU $137,582,000.00
  • STXS $27,510,000.00
  • Revenue This Year
  • INFU $11.08
  • STXS $25.90
  • Revenue Next Year
  • INFU $8.02
  • STXS $60.57
  • P/E Ratio
  • INFU $41.25
  • STXS N/A
  • Revenue Growth
  • INFU 7.98
  • STXS 1.50
  • 52 Week Low
  • INFU $4.61
  • STXS $1.54
  • 52 Week High
  • INFU $9.97
  • STXS $2.72
  • Technical
  • Relative Strength Index (RSI)
  • INFU 53.24
  • STXS 52.17
  • Support Level
  • INFU $6.09
  • STXS $2.08
  • Resistance Level
  • INFU $6.53
  • STXS $2.36
  • Average True Range (ATR)
  • INFU 0.28
  • STXS 0.12
  • MACD
  • INFU -0.04
  • STXS -0.01
  • Stochastic Oscillator
  • INFU 47.14
  • STXS 55.56

About INFU InfuSystems Holdings Inc.

InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: